Kidney Cancer Podcasts Kidney Cancer RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Endogenous retrovirus and immune response in RCC
W. Kimryn Rathmell, MD, PhD Director of the Division of Hematology and Oncology Vanderbilt University Medical Center discusses Endogenous retrovirus and immune response in RCC at the Kidney Cancer Ass... Author: kidneycancer Added: 03/30/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 30, 2019 Category: Cancer & Oncology Source Type: podcasts

Cell-free tumour DNA (cfDNA) detection in advanced renal cell carcinoma
Samra Turajlic, MD The Royal Marsden NHS Foundation Trust outlines Cell-free tumour DNA (cfDNA) detection in advanced renal cell carcinoma at the Kidney Cancer Association International Symposium 2019... Author: kidneycancer Added: 03/30/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 30, 2019 Category: Cancer & Oncology Source Type: podcasts

In Remembrance Of Martin Gore
Christopher Wood, MD MD Anderson Cancer Center expresses his thoughts on the late Martin Gore at the Kidney Cancer Association International Symposium 2019 in Dubrovnik, Croatia Author: kidneycancer Added: 03/30/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 30, 2019 Category: Cancer & Oncology Source Type: podcasts

A Tribute to Dr. Martin Gore US/International Perspective
David Quinn, MD USC Norris Comprehensive Cancer Center gives a heartfelt tribute to Dr. Martin Gore and his US/International Perspective at the Kidney Cancer Association International Symposium 2019 i... Author: kidneycancer Added: 03/30/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 30, 2019 Category: Cancer & Oncology Source Type: podcasts

Martin Gore My Friend I will Never Forget You
Bernard Escudier of the Institut Gustave Roussy in Villejuif, France reminisces about his late friend Martin Gore at the Kidney Cancer Association International Symposium 2019 in Dubrovnik, Croatia Author: kidneycancer Added: 03/30/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 30, 2019 Category: Cancer & Oncology Source Type: podcasts

Do we need a new Carmena in the IO era?
John B. Haanen MD PhD Department of Medical Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital asks the question "Do we need a new Carmena in the IO era?"at the Kidney Cancer... Author: kidneycancer Added: 03/29/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 29, 2019 Category: Cancer & Oncology Source Type: podcasts

Cytoreductive Nephrectomy Patient Perspective
Andy Thomas from Kidney Cancer Support Network discusses Cytoreductive Nephrectomy Patient Perspective at the Kidney Cancer Association International Symposium in Dubrovnik 2019 Author: kidneycancer Added: 03/29/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 29, 2019 Category: Cancer & Oncology Source Type: podcasts

PROCytoreductive Nephrectomy in Kidney Cancer
Michael Staehler, M.D. Ph.D. Head Interdisciplinary Center on Renal Tumors Department of Urology University of Munich, Germany takes the PROCytoreductive Nephrectomy in Kidney Cancer at the Kidney Ca... Author: kidneycancer Added: 03/29/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 29, 2019 Category: Cancer & Oncology Source Type: podcasts

Clinical Marker for Cytoreductive Nephrectomy?
Lorenzo Marconi, MD, FEBU Coimbra, Portugal discusses Clinical Marker for Cytoreductive Nephrectomy?<br />at the Kidney Cancer International Symposium in Dubrovnik 2019. Author: kidneycancer Added: 03/29/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 29, 2019 Category: Cancer & Oncology Source Type: podcasts

David F. McDermott, MD - Making Effective Therapeutic Choices for Advanced RCC in an Evolving Treatment Landscape: Personal Insights From the Patient CaseBook
Go online to PeerView.com/FEJ860 to view the entire program with slides. In this activity, based on a recent live symposium held at the 2019 Genitourinary Cancers Symposium in San Francisco, experts in renal cell carcinoma (RCC) dip into their patient “CaseBook” to offer insights from their own practice on how best to bridge the divide between clinical research and daily care in the management of RCC. Pairing analysis of the latest evidence with application of key clinical concepts to decision-making in a complex therapeutic landscape, the expert panel explores how best to leverage the potency of newer agents across di...
Source: PeerView CME/CE Audio Podcast - Oncology - March 27, 2019 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

How To Differentiate Between TKIs Available For Renal Cell Cancer Patients
Rana McKay, MD, Medical Oncologist, Assistant Professor of Medicine, University of California, San Diego, Discusses How To Differentiate Between TKIs Available For Renal Cell Cancer Patients. At The 2... Author: obr Added: 03/20/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 20, 2019 Category: Cancer & Oncology Source Type: podcasts

IO-TKI Combinations In Renal Cell Cancer
Michael Atkins, MD, Deputy Director, Georgetown-Lombardi Comprehensive Cancer Center, Scholl Professor and Vice Chair Department of Oncology, Georgetown University Medical Center, Discusses IO-TKI Com... Author: obr Added: 03/20/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 20, 2019 Category: Cancer & Oncology Source Type: podcasts

KEYNOTE 426 Phase III Trial In Metastatic Renal Cell Carcinoma
Michael Atkins, MD, Deputy Director, Georgetown-Lombardi Comprehensive Cancer Center, Scholl Professor and Vice Chair Department of Oncology, Georgetown University Medical Center, Discusses KEYNOTE 42... Author: obr Added: 03/20/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 20, 2019 Category: Cancer & Oncology Source Type: podcasts

Immunotherapy Biomarkers and Patient Selection [360p]
Dr. Julie Brahmer, Johns Hopkins University, discusses the use of biomarker testing and mutational burden to select patients for specific immunotherapies in lung cancer, renal cell carcinoma and melan... Author: cancergrace Added: 03/15/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2019 Category: Cancer & Oncology Source Type: podcasts

Protein Biomarkers, PD-L1, & Multifactorial
Kathleen Mahoney, M.D. Instructor, Medicine, Harvard Medical School Discusses Protein Biomarkers, PD-L1, & Multifactorial. At the Seventeenth International Kidney Cancer Symposium on Nov 2, 2018. Author: kidneycancer Added: 01/28/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 28, 2019 Category: Cancer & Oncology Source Type: podcasts